Bacsur Péter, Resál Tamás, Sarlós Patrícia, Iliás Ákos, Sümegi Liza Dalma, Kata Diána, . . . Molnár Tamás. (2024). Outcomes of treatment cessation afterswitching to subcutaneous vedolizumab treatment in inflammatory bowel diseases.
Chicago Style (17th ed.) CitationBacsur Péter, et al. Outcomes of Treatment Cessation Afterswitching to Subcutaneous Vedolizumab Treatment in Inflammatory Bowel Diseases. 2024.
MLA idézésBacsur Péter, et al. Outcomes of Treatment Cessation Afterswitching to Subcutaneous Vedolizumab Treatment in Inflammatory Bowel Diseases. 2024.
Figyelem: ezek az hivatkozások nem 100%-ban pontosak..